Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
JERUSALEM, ISRAEL/BASEL, SWITZERLAND: Global leader in pharmaceutical ingredients, Lonza Group and Teva Pharmaceutical Industries have decided to discontinue their collaboration (Teva – Lonza joint venture) for the development, manufacturing and marketing of biosimilars. The joint venture was established in 2009. The discontinuation will enable both companies to better advance their own strategies and efforts in serving those healthcare communities. Both companies will continue to explore opportunities to maximize the value of the investments and progress for affordable, efficacious and safe biosimilar treatments.
“With the discontinuation of the joint venture we will cease investing in areas that are not strategic to Lonza such as clinical developments and end product commercialization. In our assessment those investments in biosimilar will require more capital than initially planned and will also take more time until they reach the market. This is why we intend in the future to limit our role by focusing on our core expertise in the areas of contract manufacturing and cell line development,” said Dr Stephan Kutzer, COO, Pharma & Biotech Market Segment, Lonza.
© Worldofchemicals News
Login
VICTORIA, AUSTRALIA: A nitric acid leakage occurred at Orica’s Kooragang Island manufacturing facility near Newcastle, Australia. The leak was f ...
WILMINGTON, US: Ashland Inc plans to sell an elastomers unit and will consider the divestment of a water-treatment business. These transactions could ...
BRISTOL, UK: Scientists have developed a novel way of charging mobile phones using urine as the power source to generate electricity. Dr Ioannis Ierop ...
HOUSTON, US: Synthesis Energy Systems Inc, the US based energy and gasification technology company, has entered into a definitive agreement with Xuech ...
PHILADELPHIA, US: FMC Corporation has acquired all of the shares of Epax Nutra Holding III AS, Norway and Epax UK Holding III AS, UK, manufacturers of ...
HOUSTON, US: Sasol, South African-based energy and chemical company, and Ineos Olefins & Polymers have signed of a memorandum of understanding (MO ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder